Related Experiment Videos
The international collaborative study of maternal phenylketonuria: status report 1994
Insights
Maternal phenylketonuria (PKU) management is crucial for preventing fetal abnormalities. Early dietary phenylalanine restriction before and during pregnancy significantly improves offspring outcomes in women with PKU.
Area of Science:
- Metabolic disorders
- Maternal-fetal medicine
- Genetics
Background:
- Neonatal screening for phenylketonuria (PKU) has increased the number of women with PKU reaching reproductive age.
- Elevated maternal phenylalanine levels (hyperphenylalaninemia) are linked to severe fetal complications, including microcephaly, heart defects, and growth retardation.
- An estimated 3000 hyperphenylalaninemic females may be at risk for adverse pregnancy outcomes.
Purpose of the Study:
- To evaluate the effectiveness of a phenylalanine-restricted diet in mitigating fetal morbidity in women with PKU.
- To establish optimal metabolic control targets for pregnant women with PKU.
Main Methods:
- The international maternal PKU collaborative study analyzed data from 402 pregnancies.
- The study focused on dietary phenylalanine restriction and its impact on maternal blood phenylalanine levels.
- Assessment of fetal outcomes in relation to the timing and degree of metabolic control.
Main Results:
- Preliminary findings suggest that phenylalanine restriction should commence prior to conception for optimal results.
- Maintaining maternal blood phenylalanine levels between 120 and 360 mumol/l, alongside adequate nutritional support, is recommended.
- Hyperphenylalaninemic women achieving metabolic control by the 10th week of gestation showed improved offspring outcomes.
Conclusions:
- Early and consistent dietary management of PKU is essential for successful pregnancy outcomes.
- Phenylalanine restriction before conception is critical for preventing fetal abnormalities.
- Achieving metabolic control during pregnancy, even if initiated post-conception, positively impacts fetal development.
Abstract:
Neonatal screening for phenylketonuria (PKU) has created a problem as females with PKU are reaching child-bearing age. Surveys have revealed that maternal phenylalanine blood concentrations greater than 1200 mumol/l are associated with fetal microcephaly, congenital heart defects and intrauterine growth retardation. It is estimated that as many as 3000 hyperphenylalaninemic females may be at risk of producing these fetal abnormalities. To examine this problem, the international maternal PKU collaborative study was developed to evaluate the efficacy of a phenylalanine-restricted diet in reducing fetal morbidity. Preliminary findings have indicated that phenylalanine restriction should begin before conception for females with PKU planning a pregnancy. Dietary control should maintain maternal blood phenylalanine levels between 120 and 360 mumol/l and should provide adequate energy, protein, vitamin and mineral intake. Pregnant hyperphenylalaninemic females who achieved metabolic control after conception or by the 10th week of pregnancy had a better offspring outcome than anticipated. The results of 402 pregnancies are reviewed.